In NSCLC patients undergoing chemotherapy, Ganoderma lucidum spores (oral administration at 1.5 g/day) increased CD4+ T cell levels and the CD4+/CD8+ ratio, suggesting improved cellular immunity [107]. The gene discussed is CD8A; the disease is non-small cell lung carcinoma.